| 18.625 0.115 (0.62%) | 01-26 14:53 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 23.18 | 1-year : | 27.07 |
| Resists | First : | 19.85 | Second : | 23.18 |
| Pivot price | 18.87 |
|||
| Supports | First : | 18.07 |
Second : | 16.97 |
| MAs | MA(5) : | 18.73  |
MA(20) : | 18.58 |
| MA(100) : | 16.77 |
MA(250) : | 14.17 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 47.8 |
D(3) : | 53.1 |
| RSI | RSI(14): 55.5 |
|||
| 52-week | High : | 19.85 | Low : | 9.52 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SHC ] has closed above bottom band by 23.6%. Bollinger Bands are 28.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 19.09 - 19.2 | 19.2 - 19.31 |
| Low: | 18.16 - 18.28 | 18.28 - 18.41 |
| Close: | 18.29 - 18.49 | 18.49 - 18.72 |
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Tue, 20 Jan 2026
Sotera Health Company (SHC) Stock Analysis: Strong Buy Ratings and a Promising 6.56% Upside - DirectorsTalk Interviews
Sun, 18 Jan 2026
Sotera Health Company (SHC): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Sun, 18 Jan 2026
Sotera Health Company (NASDAQ:SHC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Wed, 14 Jan 2026
Is It Time To Reassess Sotera Health (SHC) After Its Strong One Year Share Price Gain? - Yahoo Finance
Mon, 12 Jan 2026
Sotera Health to Showcase Continued Revenue Growth and - GlobeNewswire
Sun, 11 Jan 2026
A Look At Sotera Health’s (SHC) Valuation After Analyst Upgrades And J.P. Morgan Conference Attention - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 284 (M) |
| Shares Float | 196 (M) |
| Held by Insiders | 2.3 (%) |
| Held by Institutions | 78.1 (%) |
| Shares Short | 7,030 (K) |
| Shares Short P.Month | 7,620 (K) |
| EPS | 0.2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.94 |
| Profit Margin | 4.8 % |
| Operating Margin | 40.5 % |
| Return on Assets (ttm) | 7.9 % |
| Return on Equity (ttm) | 10.8 % |
| Qtrly Rev. Growth | 9.1 % |
| Gross Profit (p.s.) | 2.26 |
| Sales Per Share | 4.04 |
| EBITDA (p.s.) | 1.94 |
| Qtrly Earnings Growth | 183.3 % |
| Operating Cash Flow | 240 (M) |
| Levered Free Cash Flow | 207 (M) |
| PE Ratio | 92.92 |
| PEG Ratio | 0 |
| Price to Book value | 9.57 |
| Price to Sales | 4.59 |
| Price to Cash Flow | 22.01 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|